In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 761-766

  Sheng, Jin G ^b   Ito, Kazuhiro ^b   Skinner, Robert D ^b   Mrak, Robert E ^b   Rovnaghi, Cynthia R ^b   Van Eldik, Linda J ^b   Griffin, W Sue T ^a  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b NONE

Author keywords

Alzheimer's disease; C6 glioma cells; Down's syndrome; Interleukin 1; Rats; S100 ; Amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOWN SYNDROME; GENE EXPRESSION REGULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0007692414     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00104-2     Document Type: Article

References (34)

1. 1. Allore, R.; O'Hanlon, D.; Price, R.; Neilson, K.; Willard, H. F.; Cox, D. R.; Marks, A.; Dunn, R. J. Gene encoding the β subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239:1311-1313; 1988.
2. 2. Araki, W.; Kitaguchi, N.; Tokushima, Y.; Ishii, K.; Aratake, H.; Shimohama, S.; Nakamura, S.; Kimura, J. Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture. Biochem. Biophys. Res. Commun. 181:265-271; 1991.
3. 3. Baggott, P. J.; Sheng, J. G.; Cork, L.; Del Bigio, M. R.; Brumback, R. A.; Roberts, G. W.; Mrak, R. E.; Griffin, W. S. T. Expression of Alzheimer's disease (AD)-related proteins during development in Down's syndrome. Neurosci. Soc. Abstr. 19:182; 1993.
4. 4. Ban, E. M.; Sarlieve, L. L.; Haour, F. G. Interleukin-1 binding sites on astrocytes. Neuroscience 52:725-733; 1993.
5. 5. Bhattacharyya, A.; Oppenheim, R. W.; Prevette, D.; Moore, B. W.; Brackenbury, X.; Rattner, N. S100 is present in developing chicken neurons and Schwann cells and promotes neuron survival in vivo. J. Neurobiol. 23:451-466; 1992.
6. 6. Boultwood, J.; Breckon, G.; Birch, D.; Cox, R. Chromosomal localization of murine interleukin-1 alpha and beta genes. Genomics 5:481-485; 1989.
7. 7. Buxbaum, J. D.; Oishi, M.; Chen, H. I.; Pinkas-Kramarski, R.; Jaffe, E. A.; Gandy, S. E.; Greengard, P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer α/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89:10075-10078; 1992.
8. 8. Cacabelos, R.; Alvarez, X.A.; Fernandez-Novoa, L.; Franco, A.; Mangues, R.; Pellicer, A.; Nishimura, T. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find. Exp. Clin. Pharmacol. 16:141-151; 1994.
9. 9. da Cunha, A.; Jefferson, J. J.; Tyor, W. R.; Glass, J. D.; Jannotta, F. S.; Vitkovic, L. Gliosis in human brain: Relationship to size but not other properties of astrocytes. Brain Res. 600:161-165; 1993.
10. 10. Dunn, R.; Landry, C.; O'Hanlon, D.; Dunn, J.; Allore, R.; Brown, I.; Marks, A. Reduction in S100 protein beta subunit mRNA in C6 glioma cells following treatment with anti-microtubular drugs. J. Biol. Chem. 262:3562-3566; 1987.
11. 11. Forloni, G.; Demicheli, F.; Giorgi, S.; Bendotti, C.; Angeretti, N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1. Mol. Brain Res. 16:128-134; 1992.
12. 12. Giulian, D.; Woodward, J.; Young, D. G.; Krebs, J. F.; Lachman, L. B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:2485-2490; 1988.
13. 13. Goldgaber, D.; Harris, H. W.; Hla, T.; Maciag, T.; Donnelly, R. J.; Jacobsen, J. S.; Vitek, M. P.; Gajdusek, D. C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86:7606-7610; 1989.
14. 14. Goldgaber, D.; Lerman, M.; McBride, W.; Saffioti, U.; Gajdusek, D. C. Characterization and chromosomal localization of cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877-880; 1987.
15. 15. Griffin, W. S. T.; Sheng, J. G.; Roberts, G. W.; Mrak, R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54: 276-281; 1995.
16. 16. Griffin, W. S. T.; Stanley, L. C.; Ling, C.; White, L.; Macleod, V.; Perrot, L.; White, C. L., III; Araoz, C. Brain interleukin 1 and S100 immunoreactivity are elevated in Alzheimer disease and in Down syndrome. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
17. 17. Griffin, W. S. T.; Stanley, L. C.; Yeralan, O.; Rovnaghi, C. R.; Marshak, D. R. Methods for the study of cytokines in human neurodegenerative disease. Methods Neurosci. 17:268-287; 1993.
18. 18. Marshak, D. R. S100β as a neurotrophic factor. Prog. Brain Res. 86: 169-181; 1990.
19. 19. Marshak, D. R.; Pesce, S. A.; Stanley, L. C.; Griffin, W. S. T. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging 13:1-7; 1991.
20. 20. Milward, E. A.; Papadopoulos, R.; Fuller, S. J.; Moir, R. D.; Small, D.; Beyreuther, K. Masters, C. L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9:129-137; 1992.
21. 21. Mrak, R. E.; Sheng, J. G.; Griffin, W. S. T. Glial cytokines in Alzheimer's disease. Review and pathogenic implications. Hum. Pathol. 26: 816-823; 1995.
22. 22. Rothwell, N. J. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12:430-436; 1991.
23. 23. Royston, M. C.; Rothwell, N. J.; Roberts, G. W. Alzheimer's disease: Pathology to potential treatment? Trends Pharmacol. Sci. 13:131-133; 1992.
24. 24. Rozemuller, J. M.; Eikelenboom, P.; Stam, F. C.; Beyreuther, K.; Masters, C. L. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol. 48:674-691; 1989.
25. 25. Sambrook, J.; Fritsch, E. F.; Maniatus, T. Molecular cloning: A laboratory manual, 2nd ed. vol. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989:7.39-7.52; 1989.
26. 26. Schubert, D.; Jin, L. W.; Saitoh, T.; Cole, G. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion. Neuron 3:689-694; 1989.
27. 27. Sheng, J. G.; Boop, F. A.; Mrak, R. E.; Griffin, W. S. T. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity. J. Neurochem. 63:1872-1879; 1994.
28. 28. Sheng, J. G.; Mrak, R. E.; Griffin, W. S. T. S100β protein expression in Alzheimer's disease: Potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:398-404; 1994.
29. 29. Sheng, J. G.; Mrak, R. E.; Griffin, W. S. T. Interleukin-1α expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21:290-301; 1995.
30. 30. Tanzi, R. E.; Gusella, J. F.; Watkins, P. C.; Bruns, G. A. P.; St George-Hyslop, G.; Van Keuren, M. L.; Patterson, D.; Pagan, S.; Kurnit, D. M.; Neve, R. L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880-882; 1987.
31. 31. Vandenabeele, P.; Fiers, W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol. Today 12:217-219; 1991.
32. 32. Van Eldik, L. J.; Griffin, W. S. T. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223:398-403; 1994.
33. 33. Wisniewski, K. E.; Wisniewski, H. M.; Wen, G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282; 1985.
34. 34. Yeralan, O.; Zhang, S.-X.; Rovnaghi, C. R.; Griffin, W. S. T. Quantitative micro-in situ hybridization. In: Valentino, K. L.; Eberwine, J. H.; Barchas, J. D., eds. In situ hybridization in neurobiology: Advances in methodology. New York: Oxford University Press; 1993: 108-113.